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Summary The healing activity of the ethanol extracts of Piper betel,  Emblica officinalis,
Terminalia bellerica, and Terminalia chebula against the indomethacin-induced stomach
ulceration has been studied and compared with that of misoprostol. Compared to autohealing,
all the drugs accelerated the healing process, albeit to different extents. The relative healing
activities of the extracts was P. betel>E. officinalis>T. bellerica~T. chebula, that correlated
well with their in vivo antioxidant and mucin augmenting activities. The excellent healing
activity of the extracts of P. betel and E. officinalis indicated a major role of mucin protection
and regeneration in the healing of nonsteroidal anti-inflammatory drugs mediated stomach
ulceration.
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Introduction
Gastrointestinal toxicity associated with nonsteroidal
anti-inflammatory drugs (NSAIDs) may be as high as 4–8%
per year, despite the recent pharmaceutical advances [1]. For
elderly NSAID users, fatal complications are close to 1 per
1,000 person-years of NSAID use, and higher for those with
additional risk factors, such as prior history of ulcer disease.
Various synthetic anti-ulcer drugs are presently available
and some of these like misoprostol are specifically used
to cure the NSAID induced gastric ulcer. However, each
of these drugs confers simpler to severe side effects [2],
warranting a search for non-toxic and inexpensive antiulcer
medication [3]. Investigation on dietary plants that are also
valued in the traditional systems of medicine might provide
efficient formulation for prolonged use. To this end, we have
evaluated the healing effect of different parts of five plants
viz. Piper betel, Emblica officinalis, Terminalia bellerica,
and  Terminalia chebula on indomethacin-induced acute
experimental gastric ulcerated rats and compare the activity
with that of the synthetic anti-ulcer drug, misoprostol.
All the chosen plants are valued in the Indian traditional
system of medicine, ayurveda for their multiple health benefits.
Ayurveda, the name made up of two Sanskrit words “Ayu”
(life) and “Veda” (knowledge) is a holistic system of
medicine developed in India over 5,000 years ago that uses a
constitutional model to guide people for better health. The
historical evidence of Ayurveda can be found in the ancient
books of wisdom known as the Vedas, written over 6,000
years ago. It looks each individual as a unique makeup of
the three doshas (bad effects) derived from viz. Vata
(air), Pitta (metabolism) and Kapha (fluid) and suggests
guidelines to reduce these. Thus, besides addressing specific
health concerns, it also suggests proper lifestyle for health
sustenance.
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The leaves of P. betel with a strong pungent and aromatic
flavour are widely consumed as a mouth freshner and
credited with wound healing, digestive and pancreatic lipase
stimulant activities in the traditional medicine. Its utility
against various diseases can be traced in the ancient vedic
literature, Atharved as early as 3000–2500 BC. Likewise,
the fruits of E. officinalis, T. chebula and T. bellerica are
essential ingredients of most of the Ayurvedic “rasayana”
(rejuvenation and longevity tonics) drugs and credited with
a host of health benefits. These are used individually as well
as in combination in equal proportions, the mixture being
known as triphala [‘tri’ (three in Sanskrit) and ‘phal’ (fruits
in Hindi and Sanskrit)]. Triphala is credited with several
medicinal properties. Some of the medicinal attributes of these
plants ratified worldwide by modern research and pertinent
to the present studies are mentioned in the following.
The extracts of P. betel leaves are reported to provide
cytoprotection against gastric lesions [4], and show digestive
[5], and antioxidative [6, 7] properties. The antioxidant [8,
9], and anti-ulcerogenic activities [10–12] of E. officinalis
have been confirmed. Besides its use by the tribal folks as
traditional remedies from several ailments such as fever,
cough, diarrhea, skin diseases and oral thrush, other beneficial
effects of T. bellerica are also reported [13, 14]. T. chebula is
used as an expectorant, aphrodisiac, tonic and diuretic, and
has been found effective for wound healing [15] and as an
antioxidant [16].
Materials and Methods
Chemicals and reagents
The plant parts viz. P. betel (leaves), E. officinalis (fruits),
T. chebula (fruits), and T. bellerica (fruits) were collected from
the local market and identified by the Botanical Survey of
India, Indian Botanical Garden, West Bengal. 2-Thiobarbituric
acid (TBA), Tris, ethylenediamine tetraacetic acid (EDTA) and
ethanol were procured from E. Merck (Mumbai, India), while
trichloroacetic acid (TCA) was from Thomas Baker, Mumbai,
India. Alcian blue, indomethacin, dimethylaminobenzaldehyde,
epinephrine, acetyl acetone and bovine serum albumin
(BSA) were procured from Sigma Chemicals (St. Louis,
MO). Other reagents used were H2O2 (35%, Lancaster,
Morecambe, England), and perchloric acid, K2HPO4,
KH2PO4, KOH and HCl (all from SRL, Mumbai, India).
Stock solutions of EDTA and H2O2 were prepared in triply
distilled deaerated water just prior to use. Stock solutions
(1% w/v) of TBA were prepared in 50 mM NaOH solution
and used within a week.
Preparation of the plant extracts
Fresh leaves of P. betel and sun-dried fruits of E. officinalis,
T. chebula and T. bellerica (each 250 g) were individually
extracted with 1 l of 95% ethanol at 22°C for 4 days with
intermittent shaking, and using fresh batch of solvent each
day. In each case, the supernatant was decanted and filtered
through a nylon mesh. The supernatants were concentrated
in vaccuo and finally lyophilized to obtain the respective
extracts that were stored in a vacuum dessicator. These were
designated as PBE (P. betel, 2.2% w/w), EOE (E. officinalis,
10.1% w/w), TCE (T. chebula, 10.6% w/w) and TBE (T.
bellerica, 11.2% w/w) respectively.
Preparation of the drug
The doses of the extracts (designated as drugs) used for
the studies were PBE (120 mg), EOE (100 mg), TBE and
TCE (each 200 mg)/kg body weight of rats. Each of the
extracts was macerated with a morter pestle in double
distilled water containing gum acacia (2% w/w) to provide
the drug. The drugs (1 ml per day) were administered by oral
intubation using a feeding cannula.
Experimental protocol for ulceration and healing
The rats were bred at Dr. B.C. Roy Post Graduate Institute
of Basic Medical Sciences, Kolkata, India and BARC
Laboratory Animal House Facility, Mumbai, India. These
were procured after obtaining clearance from the respective
Animal Ethics Committee of the two centres and were
handled following international Animal Ethics Committee
guidelines. Male Sprague-Dawley rats (weighing 180–
200 g) were reared on a standard laboratory diet (Ralston
Purina, Chicago, IL) and given tap water. They were kept
in a room at where temperature (24 ± 2°C), humidity (65–
70%), and day/night cycle (12 h/12 h) were controlled. A
total of 40 rats were randomly divided into 8 groups (5
animals in each group) and each set was replicated three
times. Group I rats serving as the normal control received
only the vehicle oral dose of gum acacia in distilled water
(1 ml per rat). Ulceration in the groups II–VIII rats was
induced with indomethacin (30 mg/kg body weight, oral
intubation) dissolved in distilled water. Rats were deprived
of food but had free access to tap water 24 h before ulcer
induction. Group II rats serving as the ulcerated control
received only indomethacin, and were sacrificed 4 h after
indomethacin administration. Group III rats were given the
vehicle (1 ml per rat) only for seven days. Rats in the groups
IV–VII received the drugs (PBE, EOE, TCE and TBE)
respectively, while group VIII rats received misoprostol
(1.43 µg/kg body weight) once daily by oral intubation
starting from four hour after the indomethacin administration.
After seven days, the rats of groups I, and III–VIII were
sacrificed by cervical dislocation followed by cutting off the
abdominal aortic artery.
Quantification of ulceration
The areas of mucosal damage were calculated in square
millimeters and expressed as a percentage of the surface ofS. Bhattacharya et al.
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the glandular stomach according to a reported procedure [17].
Preparation of tissue homogenate
After noting the wet weight, the stomach tissue was
homogenized in a 50 mM phosphate saline buffer (PBS) pH 7.2
under cold condition, using a glass-teflon homogenizing
tube. The homogenate was centrifuged at 2500 rpm for
10 min, the supernatant was carefully removed from the
pellet and used for the biochemical analyses.
Quantification of lipid, protein and DNA damages during
ulceration and healing
The lipid peroxidation products were estimated [18] in
terms of malondialdehyde (MDA) formation. The amounts
of protein carbonyls and DNA contents were estimated
following reported methods [19, 20].
Assessment of enzymatic activities
The specific activity of catalase (CAT) in the tissue was
estimated according to a reported method [21]. The tissue
homogenate (20 µl) was added to a H2O2-phosphate buffer
mixture (3 ml), maintaining the optical density against
buffer at 240 nm to 0.500 ± 0.010 (d = 1 cm). The rate of
change of optical density at 240 nm with time was recorded
for the calculation of the catalase activity.
Following a reported method [22], the tissue superoxide
dismutase (SOD) activity was measured. This involves
assaying the SOD-mediated inhibition of epinephrine auto-
oxidation at an alkaline medium. For this, the absorbances of
the samples at 480 nm were noted at an interval of 30 s. The
enzyme activity was measured in arbitrary units, considering
50% inhibition as 1 unit of enzyme activity.
Mucin assay
Following a reported method [23], the free mucin in the
gastric tissues was estimated by measuring the amount of
Alcian blue (Ab) bound to mucin. Briefly, the gastric tissues
were incubated with a 1% buffered solution of Ab in
aqueous 3% acetic acid (0.5 ml) at 37°C for 30 min. After
centrifuging the solution, the concentration of Ab in it was
measured from the absorbance at 615 nm.
Hexosamine assay
The hexosamine concentrations in gastric tissues were
assayed according to a reported method [24] with a minor
modification. The gastric tissues were hydrolyzed in acidic
medium, the hydrolysate neutralized with 3N NaOH (litmas)
and diluted to 10 ml with double distilled water. To an
aliquot (1 ml) was added acetyl acetone solution (1 ml,
prepared by dissolving 1 ml of acetyl acetone in 50 ml 0.5 N
sodium carbonate), the solution mixed well, and heated on a
boiling water bath for 15 min avoiding evaporation. After
cooling, ethanol (5 ml, 95%) was added to the mixture
followed by Ehrlich’s reagent (1 ml, prepared by dissolving
0.8 g para-dimethylaminobenzaldehyde in 30 ml methanol
and 30 ml conc. HCl). The mixture was diluted to 10 ml with
95% ethanol, allowed to stand for 30 min, and its absorbance
at 530 nm was read.
Estimation of the total phenolics and flavonoids contents in
the plant extracts
Following our reported method [25], the amounts of total
phenolics and flavonoids in the extracts were determined. Each
test extract (100 µl) was mixed with 1:10 Folin-Ciocalteau’s
reagent (500 µl) followed by addition of aqueous Na2CO3
(400 µl, 7.5%). After incubating the reaction mixture at
24°C for 2 h, the absorbance at 765 nm was recorded. Gallic
acid monohydrate was used as the standard. The total
phenolic contents of EOE, TCE and TBE are expressed in
terms of mg gallic acid equivalent (GAE)/g dry weight of the
plant extract.
Each extracts (100 µg) was added to 0.4 ml distilled water
followed by NaNO2 (0.03 ml, 5%). After 5 min at 25°C,
AlCl3. 6H2O (0.03 ml, 10%) was added followed by aqueous
NaOH (0.2 ml, 1 M) after 6 min. The mixture was diluted
with water to 1 ml and the absorbance at 510 nm was read.
Epicatechin was used as the standard and the total flavonoid
contents of EOE, TCE and TBE are expressed as mg
epicatechin equivalents (ECE)/g dry weight of the extract.
Statistical analyses
All the results were expressed as mean ± SE. Student’s
t test at p<0.05 was used to assess statistical significance in
various groups of animals.
Results
Effect of the drugs on gastric ulcer healing in rats
Oral administration of the plant extracts at different doses,
e.g. 50–250 mg/kg body weight for 7–10 days, accelerated
the rate of healing of gastric lesion induced by indomethacin
(data not shown). It was found that a seven day post-
ulcerative treatment with the individual drugs at the designated
doses was optimal for effective ulcer healing. Hence all
subsequent experiments were carried out with the same
protocol. The dose of the positive control, misoprostol
(1.43 µg/kg body weight) was decided based on its
recommended dose for humans.
Treatment of rats with indomethacin produced typical
acute lesions in the gastric mucosa resulting in substantial
ulcer index. This was reduced by 36.2% for the group III rats
due to autohealing. Compared to the zero day ulcerated
group (group II), treatment with PBE and EOE reduced the
ulcer index by 78.3, and 85.7% respectively. TCE and TBE
were significantly less active with 48.5 and 43.6% healing
capacities. In comparison, misoprostol (1.43 µg/kg bodyUlcer Healing Property of Kombucha and Black Teas
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weight) gave 85.4% reduction in the ulcer index. The results
are summarized in Table 1. The ulcer healing data of all the
drug-treated groups were significantly different from those
of the zero day and seven day untreated experimental control
rats (groups II and III) (p<0.05). However, the results of
groups IV and V as well as of groups VI and VII rats were
not significantly different.
The gastric tissue morphologies of the rats of groups I–V
and VIII were also observed macroscopically (Fig. 1a–f).
This revealed that compared to the vehicle treated rats, oral
administration of indomethacin (30 mg/kg) produced acute
lesions in the gastric mucosa within 4 h with number of
blood clots in the ulcer spots and perforations (cf. Fig. 1a, b).
The seven day ulcerated (untreated experimental control)
Table 1. The healing capacity of the drugs on ulcerated ratsa
Samples Dose of drug Ulcer index % Protectionb
Unulcerated control — 0 —
Ulcerated controlb — 26.71 ± 1.6 0
Ulcerated untreated control 17.62 ± 1.2 36.18 ± 1.4
Ulcerated PBE treated 120 mg/kg body weight 5.84 ± 0.3 78.28 ± 2.8
Ulcerated EOE treated 100 mg/kg body weight 3.81 ± 0.5 85.73 ± 3.7
Ulcerated TCE treated 200 mg/kg body weight 13.81 ± 1.7 48.50 ± 3.8
Ulcerated TBE treated 200 mg/kg body weight 14.31 ± 1.4 43.63 ± 2.1
Ulcerated misoprostol treated 1.43 µg/kg body weight 3.95 ± 0.3 85.40 ± 3.5
aStomach ulceration in rats was induced by oral administration of indomethacin (30 mg/kg body weight).
The doses of the drugs are as mentioned in the Materials and Methods section. The ulcer indices values
are mean ± SEM and were compared statistically by one-way ANOVA. *Significant at p<0.05 as
compared to the zero day and seven day untreated experimental control rats (groups II and III). The
values of groups IV, V and VIII were significantly different (p<0.05) from those of groups VI and VII.
However, there was no significant difference in the values of groups IV, V and VIII as well as of groups
VI and VII. bConsidering an ulcer index of 100 for the ulcerated, untreated rats; cThe ulcer indices were
measured 4 h after indomethacin administration. For other samples the measurement was carried out
after 7 days.
Fig. 1. Macroscopic assessment of the healing of acute gastric mucosal injury induced by indomethacin in rats and its prevention by
PBE, EOE and misoprostol. Section of rat stomachs obtained from a: normal control rats; b: ulcerated untreated control rats 4 h
after indomethacin administration; c: ulcerated untreated control rats 7 day after indomethacin administration; d: ulcerated rats
treated with PBE for 7 days; e: ulcerated rats treated with PBE for 7 days; f: ulcerated rats treated with misoprotsol for 7 days.S. Bhattacharya et al.
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stomach showed lesser spots but the tissues were hyaline in
nature (Fig. 1c). In comparison, stomachs of the PBE and
EOE-treated rats were healthy almost without any ulcer
spots (Fig. 1d, e). The stomachs of the rats treated with PBE
were equivalent to those of the normal control rats (group I)
(cf. Fig. 1d, a). In comparison, stomachs of the rats treated
with misoprostol showed less ulcer spots but the tissues
remained hyaline in nature (Fig. 1f).
Effect of the drugs on lipid peroxidation and DNA and
protein contents in gastric tissues
The effects of indomethacin intake alone, and following
administration of the drugs on the extent of lipid peroxidation
(measured in terms of MDA), protein oxidation (measured
in terms of proteins carbonyls), and DNA damage in the
gastric tissues of rats are shown in Table 2. Indomethacin
administration markedly stimulated lipid peroxidation in
gastric tissues, and the MDA content was elevated by about
252% compared to the unulcerated control rats. This was
reduced by 25.7% after seven days due to autohealing for the
untreated control rats (group III), although the MDA content
remained significantly high (187%) compared to that in the
normal rats. Treatment with PBE and EOE reduced it by
54.9 and 53.7% respectively, while TCE and TBE brought
them to even less than normal value (10.0 nmol/mg prot.).
Thus, amongst the test drugs, TBE and TCE could inhibit
lipid peroxidation most efficiently. The effect of misoprostol
was similar to that of EOE. The data for the treatment with
the drugs are significant compared to those of rats of groups
II and III (p<0.05).
Compared to the normal rats, the indomethacin-induced
ulceration led to extensive protein oxidation as revealed from
329% increase in the protein carbonyls content, which was
reduced by 45.3% due to autohealing. Compared to ulcerated
rats, treatment with PBE, EOE, TCE and misoprostol
reduced it by 65.1, 60.0, 60.7 and 62.4% respectively, while
the effect of TBE was much less (~54.8%). Thus, the relative
protective activities of the drugs against protein oxidation
was PBE>TCE~EOE>TBE. The data for the treatment with
the drugs are significant compared to those of the groups II
and III rats (p<0.05). The data with the groups IV–VI were
significantly different compared to that of the group VII rats
(p<0.05). However, the data of the groups IV–VI and VIII
rats were not significantly different (p<0.05).
The tissue DNA concentration was significantly (57.1%)
reduced by indomethacin administration. During autohealing,
the DNA level increased to 61.5% of the normal value.
Treatment with EOE, TCE and misoprostol brought back the
tissue DNA level to near normalcy (~1.7–1.8 for the treated
groups vs 1.82 for group I rats), while surprisingly the PBE
treatment increased the DNA level by 196% compared to the
normal rats. The augmentation of DNA by the drugs was
significant (p<0.05) as compared to the ulcerated controls
(group II). The DNA level for the TBE treated rats was only
67% of the unulcerated rats, which was similar to that
observed with autohealing.
Effect of the drugs on the SOD and CAT levels in gastric
tissues
The effect of indomethacin intake alone, and following
Table 2. The effect of the drugs on lipid, protein, DNA, SOD and CAT levels of ulcerated gastric tissue of ratsa
Samples
MDA 
(nmol/mg prot.)
Carbonyl 
(µg/mg prot.)
Total DNA 
(mg/g tissue)
SOD 
(U/min/mg prot.)
CAT 
(U/min/mg prot.)
Unulcerated control 9.96 ± 0.1 5.26 ± 1.34 1.82 ± 0.18 22.2 ± 2.34 21.2 ± 1.12
Ulcerated controlb 25.09 ± 1.4 17.29 ± 1.8 0.78 ± 0.10 5.76 ± 2.32 9.02 ± 2.54
Ulcerated control 18.64 ± 3.2 9.46 ± 2.15 1.12 ± 0.21 11.58 ± 1.32 14.2 ± 2.84
Treated with PBE 11.32 ± 2.1 6.03 ± 1.5 3.56 ± 0.05 21.14 ± 1.24 19.04 ± 2.15
Treated with EOE 11.62 ± 1.2 6.93 ± 1.6 1.65 ± 0.6 18.54 ± 2.5 19.32 ± 1.9
Treated with TCE 9.24 ± 1.6 6.80 ± 1.8 1.78 ± 0.50 21.32 ± 3.1 21.61 ± 2.2
Treated with TBE 9.60 ± 2.1 7.82 ± 1.8 1.22 ± 0.31 22.52 ± 2.3 18.61 ± 2.3
Treated with misoprostol 11.63 ± 1.5 6.54 ± 1.1 1.68 ± 0.23 16.71 ± 2.6 15.84 ± 2.1
aStomach ulceration in rats was induced by oral administration of indomethacin (30 mg/kg body weight). The doses of the drugs
are as mentioned in the Materials and Methods section. bThe assays were carried out 4 h after indomethacin administration. For
other samples these were done after 7 days. The values are mean ± SEM and were compared statistically by one-way ANOVA.
*Significant at p<0.05 as compared to the zero day and seven day untreated experimental control rats (groups II and III). The
values for protein carbonyl with the groups IV–VI and group VIII were significantly different compared to that of the group VII
rats (p<0.05), without being significantly different among each other. The values for SOD and catalase with the groups IV–VII
were significantly different compared to that of the group VIII rats (p<0.05). For SOD, the values with the groups IV, VI and VII
were significantly different compared to that of the group V rats (p<0.05), without being significantly different among each
other. For catalase, the values with the groups IV, V and VII were significantly different compared to that of the group VI rats
(p<0.05), without being significantly different among each other.Ulcer Healing Property of Kombucha and Black Teas
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administration of the drugs on the levels of SOD and CAT
in gastric tissues of rats are also presented in Table 2. The
activities of both the enzymes were reduced following
indomethacin administration. The SOD activity decreased
by 74%, while that of CAT was reduced by about 57.5%
compared to those in normal control rats. Autohealing
restored the SOD and CAT levels to 52 and 67% of the
normal values. Treatment with PBE, TCE and TBE restored
the SOD level almost to normalcy. EOE was also effective
restoring the activity by 83.3% of the normal value. Thus, all
the drugs were effective in protecting oxidative damage to SOD
with a relative protective order of TBE>TCE~PBE>EOE.
All these data were significant (p<0.05).
With CAT, TCE was very effective in restoring the
enzyme level to near normalcy. In comparison, PBE, EOE
and TBE restored the CAT level to 89.8, 91.0 and 87.7%
of the control value respectively. In this case TCE was most
effective, while the other extracts also showed impressive
CAT augmenting abilities. The effect of misoprostol was
less, increasing the SOD and CAT levels up to 75.2 and
74.5% of the normal values. The data for the SOD and CAT
levels for the drug-treated rats were significantly different
(p<0.05) from those of the untreated zero and seven day
animals (groups II and III).
Effect of drugs on hexosamine and mucin contents of gastric
mucosa
Indomethacin administration to rats decreased defensive
mucin secretion significantly as indicated by decrease in the
contents of Alcian blue-binding protein (43.5% decrease,
p<0.05) and mucosal glycoproteins (76.4% decrease,
p<0.05) in the ulcerated rats of group II compared to those
in unulcerated rats (group I). Treatment with PBE and EOE
enhanced tissue mucin levels to those in normal unulcerated
rats, while the mucosal glycoprotein content was also
increased to 65 and 61% of the normal value respectively.
Surprisingly, treatment with TCE or TBE had no effect on
the mucin level. Further, although TBE marginally improved
the hexosamine level to ~34% of the normal value, TCE
did not augment it. The results on the levels of mucin and
hexosamine are summarized in Fig. 2 and Fig. 3 respectively.
The augmentation of mucin levels by PBE and EOE were
significant (p<0.05) as compared to untreated ulcerated
controls (group II). Misoprostol also increased the mucin
secretion and mucosal glycoproteins in the ulcerated rats to
94 and 90% of the normal values.
Discussion
Currently the NSAIDs are preferred drugs for various
diseases. However, these are known to generate oxygen free
radicals that are known to play a role in the pathogenesis of
mucosal injury [26]. The antioxidants are advocated to offer
effective protection against induction and progression of
gastric ulcer. The reported medicinal attributes and anti-
oxidant property of the chosen plants triggered us to assess
their possible protective effects against indomethacin-induced
gastric lesions in rats. Although the gastrocytoprotective
properties of PBE and EOE have been reported by us [4, 10]
and others [11, 12], these do not automatically guarantee
their healing potency for the treatment of acute gastric ulcer.
The reported [12] ulcer-healing activity of E. officinalis was
based on a very limited study. Further, the study was
conducted with an extract prepared in toxic methanol, and
did not include any NSAID as the causative agent. The
present detailed study used the pharmaceutically acceptable
solvent, ethanol for preparing the plant extracts. It is also
worth noting that compared to methanol, ethanol is a better
extractant for the antioxidant phenolics.
Measurement of the ulcer indices of the rats demonstrated
that treatment with the plant extracts led to faster ulcer-
healing compared to the untreated rats. The healing potency
of the drugs was different, with a relative order of
PBE>EOE>>TCE~TBE. This was also corroborated by the
macroscopic gastric tissue morphology.
Tissue damage is always associated with lipid peroxidation,
loss of DNA content and impairment of protein synthesis
[27] due to excess generation of free radicals. These free
radicals also damage the cellular antioxidant enzymes such
as CAT, SOD and others, leading to aggravated tissue
damage during stomach ulceration [28]. Our results revealed
that the indomethacin-induced stomach ulceration was
accompanied with a severe oxidative stress in the gastric
tissues causing damages to key biomolecules such as lipids,
proteins and DNA. This was apparent from the stimulated
lipid and protein oxidation leading to increased accumulation
of MDA and protein carbonyls, as well as reduction in the
tissue DNA contents. The gastric activities of SOD and CAT
were also decreased notably following indomethacin intake.
Treatment with the drugs could bring these parameters
towards normal levels, than observed in natural recovery.
Suppression of most of the biochemical adverse effects by
the drugs might decrease the ulcer progression and promote
healing of gastric lesions induced by acute intake of indo-
methacin.
Although the phenolic contents of PBE and EOE were
less, they were rich in flavonoids accounting for their
superior ulcer-healing activities via the antioxidant action.
In contrast, the flavonoid contents of TCE and TBE were
significantly lower compared to their phenolics contents
(Table 3). Apparently, the phenolics in these are present in
more complex forms that are not easily bioavailable due to
high polarity. Consequently, both these plant-preparations
showed significantly less ulcer-healing property.
Ulcer-healing is a complex process involving a combination
of wound retraction and re-epitheliazation [29]. Release ofS. Bhattacharya et al.
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preformed mucus also plays a role in promoting epithelial
recovery after acute injury by forming a mucoid cap beneath
which re-epithelialization occurs [30]. Besides providing
significant buffering capacity for the neutralization of luminal
acid, the mucus can offer protection against the endogenous
aggressors like, acid, pepsin and oxidants produced in
the gastric lumen, as well as against exogenous damaging
agents, such as NSAIDs.
Thus, besides antioxidant action that protects the mucus
layer and arrests ulcer progression, drugs that increase the
synthesis and secretion of gastric mucus would accelerate
gastric ulcer healing. In this study, the decreased mucin
secretion in the indomethacin-administered rats indicated
reduced ability of the mucosal membrane to protect the
mucosa against hemorrhagic ulcer from physical damage
and back diffusion of hydrogen ions. The reduction in the
content of hexosamine, the major glycoprotein of gastric
mucosa further proved the decreased ability of the gastric
mucosa to withstand the offensive onslaught. Treatment
with the drugs, PBE, EOE and misoprostol significantly
accelerated the ulcer healing process, which is associated
with an increase in the mucin and hexosamine levels in the
gastric mucosa. This indicated that enhancement of the mucus
modulation by these drugs play a significant role in their
ulcer healing potency. The relative order of augmentation of
Fig. 2. The effect of drugs on mucin level of ulcerated rats.
Stomach ulceration in rats was induced by oral adminis-
tration of indomethacin (30 mg/kg body weight). The
drugs at the doses mentioned in the Materials and
methods section were administered 4 h after indomethacin
administration. The mucin assay was carried out after 7
days for all the samples except for the ulcerated control.
The assay for the ulcerated control was carried out 4 h
after indomethacin administration. 1: normal control; 2:
ulcerated control; 3: ulcerated PBE treated; 4: ulcerated
EOE treated; 5: ulcerated TCE treated; 6: ulcerated TBE
treated; 7: ulcerated misoprostol treated. The values are
mean ± SEM and were compared statistically by one-
way ANOVA. *Significant at p<0.05 as compared to the
zero day experimental control rats (group II). The values
with the groups III, IV and VII were significantly
different from that of the groups V–VI (p<0.05) without
being significantly different from each other.
Fig. 3. The effect of drugs on hexosamine levels of ulcerated
rats. Stomach ulceration in rats was induced by oral
administration of indomethacin (30 mg/kg body weight).
The drugs at the doses mentioned in the Materials and
methods section were administered 4 h after indomethacin
administration. The hexosamine assay was carried out
after 7 days for all the samples except for the ulcerated
control. The assay for the ulcerated control was carried out
4 h after indomethacin administration. 1: normal control;
2: ulcerated control; 3: ulcerated PBE treated; 4: ulcerated
EOE treated; 5: ulcerated TCE treated; 6: ulcerated TBE
treated; 7: ulcerated misoprostol treated. The values are
mean ± SEM and were compared statistically by one-
way ANOVA. *Significant at p<0.05 as compared to the
zero day experimental control rats (group II). The values
with the groups III, IV and VII were significantly different
from that of the groups V–VI (p<0.05). The values with
the group III and group IV were not significantly different
from each other, but were significantly different from
that of group VII.
Table 3. The total phenolic and flavonoid contents of the plant
extractsa
Plant 
extract
Phenolic content 
(mg GA equivalents/g)
Flavonoid content 
(mg CA equivalents/g)
PBE 32.0 ± 2.8 35.0 ± 2.1
EOE 20.0 ± 3.6 57.6 ± 3.0
TCE 277.0 ± 21.5 16.5 ± 1.9
TBE 424.5 ± 20.3 64.3 ± 2.8
aThe values are mean ± SEM (n = 4)Ulcer Healing Property of Kombucha and Black Teas
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both mucin and hexosamine by these drugs correlated well
with their ulcer healing capacities. In contrast, the auto
healing observed with the untreated control and healing
shown by the treatment with TCE and TBE can possibly be
attributed to other mechanisms.
Mucosal damage can be easily produced by the generation
of exogenous and endogenous active oxygen and free radicals
[31]. Apparently, the free radicals scavenging property of
drugs might be contributing in protecting the oxidative
damage to gastric mucosa that accelerates healing of gastric
ulcers. An increase in mucus production usually assist the
healing process by protecting the ulcer crater against irritant
stomach secretions (HCl and pepsin) [32] thereby enhancing
the rate of the local healing process.
Given that some drugs can show mild-to-severe side
effects even after short-term intake, we also evaluated the
possible toxic effects of the drugs upto a dose of 25 mg/kg
body weight with both mice and rats. There was no observ-
able physical sign change, and the animals had normal food
and water as well as stool during the experimental period.
These findings suggested that the drugs given at the current
dose do not have any potential side effects in the animals.
Conclusions
The biochemical data obtained with the tested drugs
correlated grossly with their ulcer-healing capacities. The
anomaly observed especially with TCE and TBE might
be due to the complexity of the ulcer-healing process.
Apparently, the supremacy of PBE and EOE over the other
plant extracts in healing gastric ulceration can be attributed
to their higher capacity to augment the stomach mucin level.
Overall, the present study established that the chosen plant
extracts especially PBE and EOE can heal indomethacin-
induced stomach ulceration in rats by their antioxidant
action and ability to form mucus. Earlier, our group has also
reported the cytoprotective activity of the above plant
against stomach ulceration. These results, taken together
along with their non-toxicity established the potential of
PBE and EOE as potent anti-ulcerogenic drugs. Comparison
of their efficacy with that of misoprostol further confirmed
the findings.
Ulceration due to NSAID is also believed to occur because
of non-selective inhibition of cyclooxygenase leading to
reduction in prostaglandins which, in turn, inhibits the
release of mucus. The relationship between prostaglandins
and leukotrienes is an important factor in gastric ulcers, and
many phenolic compounds are known to modulate the
arachidonic acid [33]. Thus, it would be of interest to study
the effects of the above plant extracts on the prostaglandin-
dependent pathway of healing gastric ulcer. Investigation in
this regard is currently in progress in our laboratory and the
results will be reported latter.
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